Hims and Hers Stock Drops 10% Following FTC Lawsuit: MSMN News

Shares of Hims and Hers, a telehealth startup, experienced a significant decline of 10% following news of a lawsuit filed by the Federal Trade Commission (FTC). The lawsuit accuses the company of mishandling sensitive health data and employing dubious billing practices, which has raised concerns among investors.

The FTC's allegations focus on claims that Hims and Hers improperly shared health information with major tech firms, including Meta and Snap. This revelation has sparked outrage, as consumers expect their health data to be handled with the utmost confidentiality. The agency argues that these practices violate consumer protection laws, potentially putting patients' privacy at risk.

In addition to the data-sharing accusations, the FTC's lawsuit also highlights issues related to billing practices. The agency claims that Hims and Hers misled customers regarding subscription cancellations, making it difficult for them to terminate their services. Such practices can lead to unexpected charges, further eroding consumer trust.

The fallout from the lawsuit has prompted a sharp sell-off in Hims and Hers shares, reflecting investor anxiety over potential regulatory penalties and the overall impact on the company's business model. As the telehealth industry continues to grow, the scrutiny from regulators is likely to increase, making compliance even more critical for companies in this space.

Hims and Hers, which offers a variety of health services online, has not yet publicly responded to the lawsuit. However, the company will need to take immediate action to address these allegations and reassure its customers and investors.

The FTC's intervention underscores the increasing regulatory focus on the tech and telehealth industries, particularly regarding data privacy and consumer rights. As more companies enter the digital health market, they must navigate a complex landscape of regulations designed to protect consumers while fostering innovation.

Investors will be closely monitoring the developments in this case, as the outcome could set important precedents for how telehealth companies manage sensitive health information and billing practices. The stakes are high, not just for Hims and Hers, but for the entire industry as it seeks to balance growth with regulatory compliance.

This lawsuit marks a significant moment for Hims and Hers and could have lasting implications for its operations and reputation. As the company grapples with these challenges, the future of its stock and business model hangs in the balance.

Source / Reference

Reporting by MSMN News, based on publicly available source material.

Source: CNBC Top News

Reference link: https://www.cnbc.com/2026/07/29/hims-and-hers-ftc-lawsuit-stock.html